Back to Search

DEREK EINHORN, M.D.

M.D.

Internal Medicine Physician

NPI: 1801855762IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

4301071970(MI)
Pediatrics Physician

Pediatrics

Code: 208000000X

4301071970(MI)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE

Class of 1998

Research & Publications (11)

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.
PMID 19429873·Diabetes Care·2009
8-other
Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.
PMID 18996826·Endocr Pract·2008
8-other
Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device.
PMID 17694728·J Clin Sleep Med·2007
4-observational
Glitazones and the management of insulin resistance: what they do and how might they be used.
PMID 15262299·Endocrinol Metab Clin North Am·2004
6-review
Advances in diabetes for the millennium: insulin treatment and glucose monitoring.
PMID 15647713·MedGenMed·2004
6-review
Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
PMID 12074206·Int J Clin Pract·2002
3-trial
Panel discussion on achieving glycemic control.
PMID 19667581·Postgrad Med·2001
8-other
The genesis and consequences of postprandial hyperglycemia.
PMID 19667579·Postgrad Med·2001
8-other
Office logistics: implementation of the continuous glucose monitoring system in clinical practice.
PMID 11469639·Diabetes Technol Ther·2000
8-other
Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use.
PMID 11467320·Diabetes Technol Ther·2000
4-observational
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
PMID 11192132·Clin Ther·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
39475 LEWIS DRIVE, SUITE 130
NOVI, MI 48377

Location

Practice Location

39475 LEWIS DRIVE, NOVI, MI
(248) 374-0502

Quick Facts

NPI
1801855762
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
28
Publications
11

Are you this provider?

Claim Your Profile